THALES
11.6.2024 09:01:34 CEST | Business Wire | Press release
The Queensland Digital Licence App has reached over 500,000 users since its launch on 1 November, 2023, showing a clear appetite from Queensland residents for safe and secure digital identity. Thales and Queensland Department of Transport and Main Roads (TMR) released the new app to all Queensland residents following a successful pilot and an extended trial in Townsville, where engagement with real end users, businesses, and industry groups provided valuable insights to the project in readiness for the launch.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611475244/en/
Credit: Queensland Department of Transport and Main Roads
With core technology provided by Thales, supported by development and operations from local partners Code Heroes and Aliva, the QLD Digital Licence app is simple to use, secure, and designed with data security and user privacy in mind. The app includes features such as multi-factor authentication, integration with the Queensland Digital Identity (QDI) service, and built-in verification for secure user-to-user information exchange. The app's consent-based design gives the individual control over their identity data – users can present or share information from the app by selecting from common use cases that disclose only the relevant information for the transaction, such as ‘proof of age’, which displays an ‘over 18’ screen without exposing date of birth, address, or driving information – a popular feature. The app currently provides digital driver licences, proof of age (18+) cards, and marine licences, with the potential for more digital documents in future.
Businesses that need to check identity or age requirements to provide goods or services can download the standalone (QLD) Verifier for Digital Licence app, which electronically confirms the authenticity of data received from a Digital Licence app. Digital verification is also expected to help businesses reduce the need to store sensitive identity data attributes as the process of verification is quick and simple, allowing for point-in-time verification in a wide range of use cases. The requirements to develop verification functionality are publicly available within the mobile driving licence app standard (ISO/IEC18013-5), allowing the larger ecosystem to build complementary verification solutions and enhance the usability of the digital licence in everyday life.
The QLD Digital Licence app and Verifier for Digital Licence app developed by Thales, are available now to Queensland residents via the mobile app stores.
“Nothing is more important that your private data, which should be highly protected. We are proud of the current success of the Queensland Digital Licence app, ensuring the safety and security of private information while offering a modern digital experience. The app undergoes rigorous privacy and information security testing to protect identity. It aligns with international standards for mobile driver licences, setting the standard for mobile driver licence apps across Australia and the world” commented Mark Bailey, Minister for Transport and Main Roads.
“Through this collaboration, Thales demonstrates a field-proven capacity to provide citizens with highly convenient and secure solutions, allowing them to reap the full benefits of digitalization. The Queensland Digital Licence App is a significant milestone in the digital ID market, showing the growing importance of and appetite for alignment to international standards for mobile driving licences and interoperability across country borders” said Youzec Kurp, Senior Vice President Identity and Biometric Solutions at Thales.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cybersecurity & Digital identity.
It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.
Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.
PLEASE VISIT
Thales Group
Digital Identity & Security
Thales
Thales Digital Identity and Security
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240611475244/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release
A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel
China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press release
The consumer habits reshaping global retail were built in the East — and most Western shoppers haven't yet adopted them. NIQ report shows that brands still treating live, social, and quick commerce as "emerging" risk being left behind. The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025,
Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS,Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press release
Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom